Literature DB >> 24361021

Deep brain stimulation for the treatment of severe, medically refractory obsessive-compulsive disorder.

Mark Sedrak1, William Wong2, Paul Wilson3, Diana Bruce4, Ivan Bernstein5, Suketu Khandhar6, Conrad Pappas7, Gary Heit8, Eric Sabelman9.   

Abstract

Deep brain stimulation is a rapidly expanding therapy initially designed for the treatment of movement disorders and pain syndromes. The therapy includes implantation of electrodes in specific targets of the brain, delivering programmable small and safe electric impulses, like a pacemaker, that modulates both local and broad neurologic networks. The effects are thought to primarily involve a focus in the brain, probably inhibitory, which then restores a network of neural circuitry. Psychiatric diseases can be refractory and severe, leading to high medical costs, significant morbidity, and even death. Whereas surgery for psychiatric disease used to include destructive procedures, deep brain stimulation allows safe, reversible, and adjustable treatment that can be tailored for each patient. Deep brain stimulation offers new hope for these unfortunate patients, and the preliminary results are promising.

Entities:  

Mesh:

Year:  2013        PMID: 24361021      PMCID: PMC3854809          DOI: 10.7812/TPP/13-005

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  40 in total

1.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 2.  Obsessive-compulsive disorder: the hidden epidemic.

Authors:  E Hollander
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

3.  Psychiatric treatment. General implications and lessons from recent court decisions in California.

Authors:  E Rudin; R Zimmerman
Journal:  West J Med       Date:  1978-05

Review 4.  The epidemiology and differential diagnosis of obsessive compulsive disorder.

Authors:  S A Rasmussen; J L Eisen
Journal:  J Clin Psychiatry       Date:  1992-04       Impact factor: 4.384

5.  Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases.

Authors:  L Gabriëls; P Cosyns; B Nuttin; H Demeulemeester; J Gybels
Journal:  Acta Psychiatr Scand       Date:  2003-04       Impact factor: 6.392

Review 6.  Understanding obsessive-compulsive disorder: focus on decision making.

Authors:  Paolo Cavedini; Alessandra Gorini; Laura Bellodi
Journal:  Neuropsychol Rev       Date:  2006-03       Impact factor: 7.444

7.  A diffusion tensor imaging study of white matter in obsessive-compulsive disorder.

Authors:  Paul A Cannistraro; Nikos Makris; James D Howard; Michelle M Wedig; Steven M Hodge; Sabine Wilhelm; David N Kennedy; Scott L Rauch
Journal:  Depress Anxiety       Date:  2007       Impact factor: 6.505

8.  Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.

Authors:  B D Greenberg; L A Gabriels; D A Malone; A R Rezai; G M Friehs; M S Okun; N A Shapira; K D Foote; P R Cosyns; C S Kubu; P F Malloy; S P Salloway; J E Giftakis; M T Rise; A G Machado; K B Baker; P H Stypulkowski; W K Goodman; S A Rasmussen; B J Nuttin
Journal:  Mol Psychiatry       Date:  2008-05-20       Impact factor: 15.992

9.  Stereotactic lesioning for mental illness.

Authors:  M-C Kim; T-K Lee
Journal:  Acta Neurochir Suppl       Date:  2008

10.  Suicidal behavior in obsessive-compulsive disorder.

Authors:  Prakash Kamath; Y C Janardhan Reddy; Thennarasu Kandavel
Journal:  J Clin Psychiatry       Date:  2007-11       Impact factor: 4.384

View more
  1 in total

1.  Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Long Term Naturalistic Follow Up Study in a Single Institution.

Authors:  Marshall T Holland; Nicholas T Trapp; Laurie M McCormick; Francis J Jareczek; Mario Zanaty; Liesl N Close; James Beeghly; Jeremy D W Greenlee
Journal:  Front Psychiatry       Date:  2020-02-28       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.